How heterogeneous are oligodendroglia from normal human brain and spinal cord?

点击翻译按钮获取中文摘要

The intricacies of the human brain are probably what define us as human, and the oligodendrocytes of the brain are vital in maintaining this. These cells extend processes of their cell membrane to wrap insulating myelin sheaths around nerve fibres, allowing electrical impulses to travel quickly along nerves, and they also nourish the underlying nerve, helping it to survive healthily. This process of myelination happens mostly after birth in humans, and allows the normal development of a baby into an adult. However, it can be disrupted around birth, due to gene defects or premature birth, in adulthood in diseases such as multiple sclerosis and in old age, either in normal ageing, or in other neurodegenerative diseases.We used to consider all oligodendrocytes as very similar, but we now know that they are likely to exist as different subtypes, perhaps depending on where they came from in development, where they exist in the brain and spinal cord, and depending on the age and sex of the human. They may also change their type in disease. We call this heterogeneity, and the best way to determine how different cells are is to consider them individually. We are now able to examine the RNA messages (which define how a cell behaves) in individual cells, comparing them with other individual cells, and finding out how similar and how different these are using computer programs, allowing thousands of comparisons in an objective way. We can then try and confirm the computer's predictions using techniques to label single RNA molecules, identifying which cells they are in and where they are in brain tissue using antibodies.In this project, we will extract oligodendrocytes from human post mortem brain and spinal cord tissue from male and female babies, young adults and old adults, from two different brain regions and spinal cord, detect the RNAs in each individual oligodendrocyte and then study the similarities and differences. This will allow us to identify subtypes of oligodendrocytes that behave differently, and that might be more vulnerable to disease or ageing in males and females. In the future, we can then compare oligodendrocytes from people with other oligodendrocyte diseases with these, and develop therapies that target the subtype of oligodendrocytes to help the disease, in a very specific way.This will be part of the Human Cell Atlas where all data will be stored and pooled from researchers all around the world, allowing free access and collaboration, which the aim of improving and accelerating biological and medical research.